Guillain-Barré syndrome after COVID-19 vaccination: report of two cases from Vietnam

Authors

  • Pham Dang Hai Intensive Care Unit, 108 Military Central Hospital, Hanoi, Vietnam https://orcid.org/0000-0001-9300-231X
  • Le Lan Phuong Intensive Care Unit, 108 Military Central Hospital, Hanoi, Vietnam
  • Nguyen Hong Tot Intensive Care Unit, 108 Military Central Hospital, Hanoi, Vietnam https://orcid.org/0000-0002-1760-3348
  • Nguyen Le Phuong Anh University of Sydney, Australia
  • Nguyen Dinh Tung College of Health Sciences,Vin University, Vietnam
  • Nguyen Hong Quan Department of Neurology, 108 Military Central Hospital, Hanoi, Vietnam https://orcid.org/0000-0003-4857-628X

DOI:

https://doi.org/10.3855/jidc.16998

Keywords:

Guillain-Barré Syndrome, GBS, COVID-19 vaccination, plasmapheresis

Abstract

Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization in March 2020 and since then it has spread to almost every country around the world. Vaccines against COVID-19 are considered an essential measure to curb this pandemic. However, side effects, including local and systemic reactions, after administering the COVID-19 vaccine have been defined, and some side effects have been reported. We present two cases of Guillain-Barré Syndrome (GBS) after receiving the ChAdOx1 nCoV-19 vaccine (Oxford- AstraZeneca). Both cases were admitted to the 108 Military Central Hospital, Vietnam, and received plasmapheresis therapy with satisfactory recovery after treatment.

Downloads

Published

2022-11-29

How to Cite

1.
Hai PD, Phuong LL, Tot NH, Anh NLP, Tung ND, Quan NH (2022) Guillain-Barré syndrome after COVID-19 vaccination: report of two cases from Vietnam. J Infect Dev Ctries 16:1703–1705. doi: 10.3855/jidc.16998

Issue

Vol. 16 No. 11: November 2022

Section

Coronavirus Pandemic

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC